GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » EV-to-Revenue

G&E Healthcare Co (XKRX:299480) EV-to-Revenue : (As of Jun. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, G&E Healthcare Co's enterprise value is ₩6,649.35 Mil. G&E Healthcare Co does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate G&E Healthcare Co's EV-to-Revenue at this moment.

The historical rank and industry rank for G&E Healthcare Co's EV-to-Revenue or its related term are showing as below:

XKRX:299480's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.92
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-12), G&E Healthcare Co's stock price is ₩599.00. G&E Healthcare Co does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate G&E Healthcare Co's PS Ratio at this moment.


G&E Healthcare Co EV-to-Revenue Historical Data

The historical data trend for G&E Healthcare Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co EV-to-Revenue Chart

G&E Healthcare Co Annual Data
Trend
EV-to-Revenue

G&E Healthcare Co Semi-Annual Data
EV-to-Revenue

Competitive Comparison of G&E Healthcare Co's EV-to-Revenue

For the Biotechnology subindustry, G&E Healthcare Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Healthcare Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Healthcare Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where G&E Healthcare Co's EV-to-Revenue falls into.



G&E Healthcare Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

G&E Healthcare Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6649.345/
=


G&E Healthcare Co  (XKRX:299480) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

G&E Healthcare Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=599.00/
=


G&E Healthcare Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines